KR20090114380A - Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence - Google Patents

Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence Download PDF

Info

Publication number
KR20090114380A
KR20090114380A KR1020097016144A KR20097016144A KR20090114380A KR 20090114380 A KR20090114380 A KR 20090114380A KR 1020097016144 A KR1020097016144 A KR 1020097016144A KR 20097016144 A KR20097016144 A KR 20097016144A KR 20090114380 A KR20090114380 A KR 20090114380A
Authority
KR
South Korea
Prior art keywords
nucleotide sequence
sequence
recombinant
nucleic acid
dna
Prior art date
Application number
KR1020097016144A
Other languages
Korean (ko)
Inventor
파벨 키스리크
바클라브 스테파네크
렌카 홀레로바
스타니슬라브 벡카
윌리암스 라자세카르 비아사라야니
다트라 아누파마
카밀라 플학코바
자로슬라브 마르사레크
Original Assignee
페르멘타 바이오테크 리미티드
미크로바이올로직키 우스탁 에이브이씨알 브이.브이.아이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 페르멘타 바이오테크 리미티드, 미크로바이올로직키 우스탁 에이브이씨알 브이.브이.아이. filed Critical 페르멘타 바이오테크 리미티드
Publication of KR20090114380A publication Critical patent/KR20090114380A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/84Penicillin amidase (3.5.1.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01011Penicillin amidase (3.5.1.11), i.e. penicillin-amidohydrolase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence having the length of at least 150 nucleotides. The sequence can be used in the formation of a DNA construct, eventually the construct having at least one regulatory sequence regulating the expression of the gene and the production of a polypeptide with the penicillin acylase activity. The sequence can form part of a recombinant expression vector, which consists of the above-mentioned construct, promoter, translational start signal, translational and transcriptional stop signal. Further, the invention concerns a recombinant host cell, containing the nucleic acid construct carried by the vector or integrated into the cell chromosome, and the E. coli BL21 strain containing said sequence of the nucleotides encoding the penicillin acylase carried in the pKXIPl, the pKLP3 or the pKLP6 plasmid.

Description

페니실린 아실라아제를 코딩하는 DNA 서열, 신규의 재조합 DNA 구조체 및 상기 서열을 갖는 재조합 미생물{DNA SEQUENCE ENCODING PENICILLIN ACYLASE, NOVEL RECOMBINANT DNA CONSTRUCTS AND RECOMBINANT MICROORGANISMS CARRYING THIS SEQUENCE}DNA SEQUENCE ENCODING PENICILLIN ACYLASE, NOVEL RECOMBINANT DNA CONSTRUCTS AND RECOMBINANT MICROORGANISMS CARRYING THIS SEQUENCE}

본 발명은 폴리펩타이드 페니실린 아실라아제를 코딩하는 DNA 서열, 신규의 재조합 DNA 구조체 및 상기 서열를 갖는 재조합 미생물에 관한 것이다.The present invention relates to a DNA sequence encoding a polypeptide penicillin acylase, a novel recombinant DNA construct and a recombinant microorganism having the sequence.

페니실린 아실라아제(E.C. 3.5.1.11, 페니실린 아미도히드롤라아제)는 박테리아, 방선균, 곰팡이 및 효모에 의해 생산된다. 이들 중요한 산업적 효소들은 이들의 기질 특이성에 기초하여 3개의 군으로 나누어 진다: 페니실린 G 아실라아제(PGA), 페니실린 V 아실라아제(PVA) 및 α-아미노산의 에스테르 히드롤라아제(AEH, 종래에는 암피실린 아실라아제로 명명됨). PGA 군의 효소는 광범위한 기질 특이성을 가지고 있으며, 페니실린 및 세팔로스포린의 아미드 결합(amidic bond)의 가수분해를 촉매화한다. 이중, 다음 속(genera)의 종들(species)이 PGA의 박테리아 생산균주에 속한다: 에어로모나스(Aeromonas), 아크로모박터(Achromobacter), 알카리젠스(Alcaligenes), 아르쓰로박터(Arthrobacter), 바실루스(Bacillus), 코리네박테리움(Corynebacterium), 에스케리치아(Escherichia), 에르위니아(Erwinia), 플라 보박테리움(Flavobacterium), 클루이베라(Kluyvera), 마이크로코쿠스(Micrococcus), 노카르디아(Nocardia), 프로테우스(Proteus), 프로비덴시아(Providencia), 슈도모나스(Pseudomonas), 사르시나(Sarcina), 산토모나스(Xanthomonas), 크실렐라(Xylella)(Process Biochem. 24:146-154, 1989, Process Biochem. 27:131-143,1992, Biotechnol. Adv. 18:289-301, 2000).Penicillin acylase (E.C. 3.5.1.11, penicillin amidohydrolase) is produced by bacteria, actinomycetes, fungi and yeast. These important industrial enzymes are divided into three groups based on their substrate specificities: penicillin G acylase (PGA), penicillin V acylase (PVA) and ester hydrolases of α-amino acids (AEH, conventionally). Named ampicillin acyla). Enzymes of the PGA family have a wide range of substrate specificities and catalyze the hydrolysis of the amide bonds of penicillin and cephalosporins. Of these, the following genera are among the bacterial production strains of PGA: Aeromonas, Achromobacter, Alcaligenes, Arthrobacter, and Bacillus ( Bacillus, Corynebacterium, Escherichia, Erwinia, Flavobacterium, Kluyvera, Micrococcus, Nocardia ), Proteus, Providencia, Pseudomonas, Sarrcina, Xanthomonas, Xylella (Process Biochem. 24: 146-154, 1989, Process Biochem) 27: 131-143, 1992, Biotechnol. Adv. 18: 289-301, 2000).

돌연변이(mutagenesis)에 의해 얻어진 PGA를 발현하는 생산균주와는 별도로, PGA를 코딩하는 구조 유전자를 갖는 재조합 플라스미드를 함유하는 재조합 미생물이 에스케리치아 콜라이(Escherichia coli) (CS 244 343 및 CS 246 957), 알카리젠스(Alcaligenes) sp. 또는 피칼리스(fecalis) (Current Microbiology 39:2444-2448, 1999; EP 638649, Appl. Environ. Microbiol. 63: 3412-3418, 1997), 아르쓰로박터 비스코수스(Arthrobacter viscosus) (Appl. Environ. Microbiol. 54: 2603-2607, 1988 a 55: 1351-1356, 1989; Gene 143: 79-83,1994), 바실루스 메가테리움(Bacillus megaterium) (J. Bacteriol. 93: 302-306, 1967, Appl. Microbiol. Biotechnol. 25: 372-378, 1987; US 3 145 395; Process Biochemistry 29: 263-270, 1994), 클루이베라 시트로필라(Kluyvera citrophila) (Agric. Biol. Chem. 39: 1225-1232, 1975; Gene 49: 69-80, Biotechnol.Letters 14: 285-290, 1992), 프로비덴시아 레트게리(Providencia rettgeri) (Acta Biochim. Polonica 28: 275-284, 1981; J. Bacteriol. 168: 431-433, 1986; DNA sequences 3: 195-200, 1992)로부터 제조된 바 있다.Apart from the production strain expressing PGA obtained by mutationsis, recombinant microorganisms containing a recombinant plasmid with a structural gene encoding PGA are Escherichia coli (CS 244 343 and CS 246 957). , Alcaligenes sp. Or fecalis (Current Microbiology 39: 2444-2448, 1999; EP 638649, Appl. Environ.Microbiol. 63: 3412-3418, 1997), Arthrobacter viscosus (Appl. Environ. Microbiol. 54: 2603-2607, 1988 a 55: 1351-1356, 1989; Gene 143: 79-83, 1994), Bacillus megaterium (J. Bacteriol. 93: 302-306, 1967, Appl Microbiol.Biotechnol. 25: 372-378, 1987; US 3 145 395; Process Biochemistry 29: 263-270, 1994), Kluyvera citrophila (Agric. Biol. Chem. 39: 1225-1232). , 1975; Gene 49: 69-80, Biotechnol. Letters 14: 285-290, 1992), Providencia rettgeri (Acta Biochim. Polonica 28: 275-284, 1981; J. Bacteriol. 168: 431-433, 1986; DNA sequences 3: 195-200, 1992).

PGA의 대부분의 원핵 제조균주는 그람-음성 박테리아이며, 상기 효소는 상기 세포의 주변세포질(periplasma)에 위치한다. 바실루스 메가테리움(Bacillus megaterium) 배양에 있어서, 상기 효소는 세포로부터 배지로 분비된다.Most prokaryotic strains of PGA are Gram-negative bacteria and the enzyme is located in the periplasma of the cell. In Bacillus megaterium culture, the enzyme is secreted from the cells into the medium.

상기 페니실린 G 아실라아제는 주로 중간체인 6-APA 및 7-ADCA의 제조를 목적으로 세팔로스포린 및 페니실린 G의 페닐아세틸 유도체의 가수분해를 위해 산업적으로 사용된다. 현재, 상기 효소들은 또한 합성 반응에서, 상기한 중간체의 아실화에서 사용되어, 반-합성 항생물질의 제조로 이어진다(예를 들어, US 5 753 458 및 US 5 801 011; WO 98/04732; WO 97/04086; Enzyme Microb. Technol. 25: 336-343, 1999; β-락탐 항생물질의 합성: Chemistry, Biocatalysis and Process Integration, Ed.: A. Bruggink, Kluwer Academic Publishers, Dordrecht/Boston/London, 2001).The penicillin G acylase is used industrially for the hydrolysis of cephalosporins and phenylacetyl derivatives of penicillin G mainly for the preparation of intermediates 6-APA and 7-ADCA. Currently, these enzymes are also used in the synthesis reactions, in the acylation of the intermediates described above, leading to the production of semi-synthetic antibiotics (eg US 5 753 458 and US 5 801 011; WO 98/04732; WO 97/04086; Enzyme Microb.Technol. 25: 336-343, 1999; Synthesis of β-lactam antibiotics: Chemistry, Biocatalysis and Process Integration, Ed .: A. Bruggink, Kluwer Academic Publishers, Dordrecht / Boston / London, 2001 ).

효소 반응의 촉매화에 있어서 상기 PGA의 연속적이고 장기간의 사용을 위하여, 상기 효소는 고정화(immobilization) 혹은 캡슐화(encapsulation)로 안정화시켜 효소 촉매를 형성한다. 이러한 형태에서, 상기 효소는 반응 과정을 촉매화하는 반응 조건하에서, 더 높은 pH 안정성, 온도 안정성 및 더욱 긴 반감기를 나타낸다.For continuous and prolonged use of the PGA in catalyzing the enzyme reaction, the enzyme is stabilized by immobilization or encapsulation to form the enzyme catalyst. In this form, the enzyme exhibits higher pH stability, temperature stability and longer half-life under reaction conditions that catalyze the reaction process.

본 발명의 목적은 2646 bp 크기의 뉴클레오티드 서열로서, 상기 뉴클레오티드 서열이 도 5에 나타낸 뉴클레오티드 서열과 적어도 95%의 동일성을 갖는 뉴클레오티드 서열이다.An object of the present invention is a nucleotide sequence of size 2646 bp, the nucleotide sequence having at least 95% identity with the nucleotide sequence shown in FIG. 5.

본 발명의 일 태양은 또한 페니실린 아실라아제를 코딩하는, 적어도 150 뉴클레오티드의 길이를 갖는, 본 발명에 따른 뉴클레오티드 서열의 단편이다.One aspect of the invention is also a fragment of the nucleotide sequence according to the invention, which has a length of at least 150 nucleotides, which encodes penicillin acylase.

본 발명의 다른 태양은 본 발명의 뉴클레오티드 서열 또는 본 발명의 뉴클레오티드 서열의 단편을 포함하는 핵산 구조체로서, 상기 유전자의 발현 및 페니실린 아실라아제 활성을 갖는 폴리펩타이드의 생산을 조절하는 적어도 하나의 조절 서열(reguatory sequence)을 갖는 핵산 구조체이다.Another aspect of the invention is a nucleic acid construct comprising a nucleotide sequence of the invention or a fragment of a nucleotide sequence of the invention, wherein at least one regulatory sequence modulates the expression of said gene and the production of a polypeptide having penicillin acylase activity. It is a nucleic acid construct having a (reguatory sequence).

본 발명의 또다른 태양은 본 발명의 뉴클레오티드 서열 또는 본 발명의 뉴클레오티드 서열의 단편을 포함하는 재조합 플라스미드이다.Another aspect of the invention is a recombinant plasmid comprising a nucleotide sequence of the invention or a fragment of a nucleotide sequence of the invention.

본 발명의 또다른 태양은 본 발명의 핵산 구조체, 프로모터, 번역 개시 신호, 및 번역과 전사 정지 신호로 구성된 재조합 발현 벡터이다.Another aspect of the invention is a recombinant expression vector consisting of the nucleic acid construct, promoter, translation initiation signal, and translation and transcription stop signal of the invention.

본 발명의 또다른 태양은 본 발명의 핵산 구조체를 포함하는 숙주 세포이다. 상기 숙주 세포에 있어서, 상기 핵산 구조체는 본 발명의 재조합 발현 벡터 중에 유지되거나(carried) 혹은 상기 세포 게놈으로 통합(integration)될 수 있다.Another aspect of the invention is a host cell comprising the nucleic acid construct of the invention. In the host cell, the nucleic acid construct may be maintained in the recombinant expression vector of the present invention or integrated into the cell genome.

본 발명의 또다른 태양은 본 발명의 뉴클레오티드 서열이 삽입되고, 균주 아크로모박터(Achromobacter) sp.로부터 분리되고, 도 1 및 2에 따른 제한 지도를 특징으로 하는, 재조합 플라스미드 pKX1P1, pKLP3 및 pKLP6이다Another aspect of the invention is the recombinant plasmids pKX1P1, pKLP3 and pKLP6, wherein the nucleotide sequences of the invention are inserted, isolated from strain Achromobacter sp., And characterized by restriction maps according to FIGS. 1 and 2.

본 발명의 또다른 태양은 상기 플라스미드 pKX1P1, pKLP3 및 pKLP6에 의해 전달되는 본 발명의 서열을 포함하는 균주 에스케리치아 콜라이 (Escherichia coli) BL21이다.Another aspect of the invention is strain Escherichia coli BL21 comprising the sequence of the invention carried by the plasmids pKX1P1, pKLP3 and pKLP6.

본 발명의 기초는 2646 bp 크기의 뉴클레오티드 서열로서, 상기 뉴클레오티드 서열이 도 5에 나타낸 뉴클레오티드 서열과 동일한 뉴클레오티드 서열이며, 궁극적으로 페니실린 아실라아제를 코딩하는, 적어도 150 염기의 길이를 갖는, 상기 뉴클레오티드 서열의 단편이다. 상기 서열은 DNA 구조체, 재조합 플라스미드 및 벡터의 일부를 형성할 수 있다. 적절한 벡터에 의해, 상기 서열은 박테리아 혹은 효모 숙주의 게놈내로 삽입될 수 있으며, 이 후 상기 숙주는 페니실린 아실라아제의 생산에 사용될 수 있다. The basis of the present invention is a nucleotide sequence of size 2646 bp, the nucleotide sequence being the same nucleotide sequence as the nucleotide sequence shown in FIG. 5 and ultimately having a length of at least 150 bases that encodes penicillin acylase. Is a fragment of. The sequence may form part of a DNA construct, a recombinant plasmid and a vector. By means of a suitable vector, the sequence can be inserted into the genome of a bacterial or yeast host, which can then be used for the production of penicillin acylase.

본 발명의 가능한 구현예 중 하나는 재조합 플라스미드 pKX1P1을 포함하는 균주 에스케리치아 콜라이(Escherichia coli) BL21(pKXlPl) (CCM 7394) 이며, 페니실린 아실라아제 활성을 갖는 새롭게 분리된 구조 유전자의 뉴클레오티드 서열을 기초로 제조된다. 상기 플라스미드는 (SD 서열을 갖는 부위를 포함하는) 2646 bp 크기를 갖는 DNA 단편이 플라스미드 벡터 pK19 (R. D. Pridmore, Gene 56: 309-312, 1987)로 삽입된 것을 특징으로 하며, 또한 도 1에 나타낸 제한 지도를 특징으로 한다. 상기 재조합 미생물의 제조는 균주 아크로모박터(Achromobacter) sp. CCM 4824 (원래 코마모나스 테스토스테로니(Comamonas testosteroni) CCM 4824; Plhackova et al., Appl. Microbiol. Biotechnol. 62: 507-516, 2003)의 세포로부터 염색체 DNA의 분리 및 상기 염색체 DNA의 5.1 kb 단편을 갖는 재조합 미생물 E. coli TOP10(pKLP3)의 제조로 구성된다. 상기 구조 유전자 pga 의 뉴클레오티드 서열은 플라스미드 pKLP3의 DNA를 사용하여 PCR 기술 (중합효소 연쇄 반응)에 의해 얻어졌다. 상기 유전자의 결정된 NT 서열에 따라, DNA 프라이머들을 고안하였으며(표 1), 이들은 동일한 PCR-서열분석(PCR-sequencing) 기술에 의한 SD 서열과 함께 조절 부위를 포함하는, 유전자의 전체 뉴클레오티드 서열을 결정하는데 사용되었다. 전체 뉴클레오티드 서열에 기초하여, 페니실린 아실라아제에 대한 총 구조 유전자의 PCR-증폭을 제공하는 프라이머들이 고안되었다 (PCR; W. Rychlik: Methods in Molecular Biology 15, 31-39, 1993). 균주 아크로모박터(Achromobacter) sp. CCM 4824의 염색체 DNA가 주형으로서 사용되었다. 얻어진 PCR 산물을 분리하고, 다중복사(multicopy) 플라스미드 pK19 (R. D. Pridmore, Gene: 309-312,1987)에 접합(ligation)시켜, 재조합 플라스미드를 얻고, 이어서 숙주 균주 에스케리치아 콜라이(Escherichia coli) TOPlO (Invitrogen, 미국)의 형질전환을 위해 사용하였다.One possible embodiment of the invention is the strain Escherichia coli BL21 (pKXlPl) (CCM 7394) comprising the recombinant plasmid pKX1P1, and the nucleotide sequence of the newly isolated structural gene having penicillin acylase activity Is made on the basis. The plasmid is characterized in that the DNA fragment having a size of 2646 bp (including the site having the SD sequence) is inserted into the plasmid vector pK19 (RD Pridmore, Gene 56: 309-312, 1987), and also shown in FIG. It features a restriction map. Preparation of the recombinant microorganism is strain Achromobacter ( Achromobacter ) sp. Isolation of chromosomal DNA from cells of CCM 4824 (originally Comamonas testosteroni CCM 4824; Plhackova et al., Appl. Microbiol. Biotechnol. 62: 507-516, 2003) and 5.1 kb fragments of the chromosomal DNA And recombinant microbial E. coli TOP10 (pKLP3). The nucleotide sequence of the structural gene pga was obtained by PCR technique (polymerase chain reaction) using the DNA of plasmid pKLP3. According to the determined NT sequence of the gene, DNA primers were designed (Table 1), which determined the entire nucleotide sequence of the gene, including the regulatory site, along with the SD sequence by the same PCR-sequencing technique. It was used to Based on the entire nucleotide sequence, primers have been devised that provide PCR-amplification of the total structural genes for penicillin acylase (PCR; W. Rychlik: Methods in Molecular Biology 15, 31-39, 1993). Strain Achromobacter sp. Chromosome DNA of CCM 4824 was used as template. The obtained PCR product was isolated and conjugated to a multicopy plasmid pK19 (RD Pridmore, Gene: 309-312,1987) to obtain a recombinant plasmid, followed by the host strain Escherichia coli TOPlO. (Invitrogen, USA) was used for transformation.

컴피턴트(competent) 세포의 제조 및 다수의 재조합 플라스미드에 의한 숙주 균주의 형질전환은 H. Hanahan, J. MoI. Biol. 166: 557-580, 1983에 따라 수행되었다. 키워진 콜로니로부터, 재조합 플라스미드를 알칼리 용균법(alkaline lysis method)(HC. Birnboim a J. DoIy: Methods in Enzymology 100, 243-254, 1983)에 의해 분리하였으며, 삽입된 단편의 크기 및 그 방향(orientation)을 결정하였다.Preparation of competent cells and transformation of host strains with a number of recombinant plasmids are described in H. Hanahan, J. MoI. Biol. 166: 557-580, 1983. From grown colonies, recombinant plasmids were isolated by alkaline lysis method (HC. Birnboim a J. DoIy: Methods in Enzymology 100, 243-254, 1983), and the size and orientation of the inserted fragments ) Was determined.

숙주 TOPlO의 선택된 콜로니 중에서, 효소 페니실린 아실라아제의 활성을 LB 배지 중에서 뱃치 배양으로 시험하였다. 가장 높은 PGA의 전체 활성을 갖는 균주로부터 분리한 재조합 플라스미드를 pKX1P1로 지정하였다. 상기 플라스미드 구조체로부터, pga 유전자를 구조적으로 발현시켰다. 이어서, 상기 숙주 균주 BL21를 상기 플라스미드로 형질전환시켰다.In selected colonies of host TOP10, the activity of the enzyme penicillin acylase was tested by batch culture in LB medium. Recombinant plasmids isolated from strains with the highest overall activity of PGA were designated pKX1P1. From the plasmid construct, the pga gene was structurally expressed. The host strain BL21 was then transformed with the plasmid.

플라스미드 pKX1P1를 지니고 있고 또한 페니실린 아실라아제를 생산하는 얻어진 재조합 균주 에스케리치아 콜라이(Escherichia coli)를 교반되는 바이오반응기 중에서 배양하였다. 최적 과정은 탄소원 및 에너지원으로서 카제인 가수분해물 및 글리세롤로 보충된 미네랄 배지 M9 상에서 상기 균주를 배양하는 것이다. pH를 5.5 내지 7.5의 범위로 유지하고, 배지내 용존 산소 농도를 10 내지 40 %로 유지하면서, 유가 배양(fed batch cultivation)을 20 내지 30 ℃ 범위의 온도에서 수행하였다.The resulting recombinant strain Escherichia coli with plasmid pKX1P1 and also producing penicillin acylase was incubated in a stirred bioreactor. The optimal procedure is to incubate the strain on mineral medium M9 supplemented with casein hydrolysate and glycerol as the carbon and energy source. Fed batch cultivation was performed at a temperature in the range of 20 to 30 ° C. while maintaining the pH in the range of 5.5 to 7.5 and maintaining the dissolved oxygen concentration in the medium at 10 to 40%.

도 1은 재조합 플라스미드 pKX1P1의 제한 지도를 나타낸다.1 shows a restriction map of recombinant plasmid pKX1P1.

도 2는 플라스미드 pKAGSau401, pKLP3 및 pKLP6를 나타낸다.2 shows the plasmids pKAGS au 401, pKLP3 and pKLP6.

도 3은 교반되는 바이오반응기 내에서 균주 BL21(pKXlPl)의 유가 배양 중, 배양물의 광학밀도((OD600) 및 세포 (건조물(dry mass))의 건조 중량의 추이를 나타낸다.FIG. 3 shows the transition of the optical density ((OD600)) and dry weight of cells (dry mass) of the culture during fed-batch culture of strain BL21 (pKXlPl) in a stirred bioreactor.

도 4는 교반되는 바이오반응기 내에서 균주 BL21(pKXlPl)의 유가 배양 중, 총 활성 (TA) 및 특이적 활성 (SA)의 추이를 나타낸다.Figure 4 shows the trend of total activity (TA) and specific activity (SA) during fed-batch culture of strain BL21 (pKXlPl) in a stirred bioreactor.

도 5는 구조 유전자 pga 및 인접 부위의 뉴클레오티드 서열을 나타낸다.5 shows the structural gene pga and the nucleotide sequence of the contiguous site.

실시예 1Example 1

A. sp.의 배양 및 염색체 DNA의 분리 A. Culture of sp. and Isolation of Chromosome DNA

아크로모박터(Achromobacter) sp. CCM 4824(Skrob et al., Enzyme Microbiol. Technol. 32:738-744, 2003; Plhackova et al., Appl. Microbiol. Biotechnol. 62: 507-516, 2003)의 토양 분리물을 50 ml의 LB 배지(g/1로: 트립톤 10, 효모 추출물 5, NaCl 5; pH 7.2-7.5) 중에서 37 ℃에서 회전 교반기(rotating shaker)(200 rpm) 상에서 12 - 16 시간 동안 배양하였다. 2 ml의 배양물로부터의 균체(biomass)를 원심분리에 의해 배지로부터 분리하고, 식염수 용액으로 세척하고, -20 ℃에서 보관하였다. Achromobacter sp. Soil isolates of CCM 4824 (Skrob et al., Enzyme Microbiol. Technol. 32: 738-744, 2003; Plhackova et al., Appl. Microbiol. Biotechnol. 62: 507-516, 2003) were placed in 50 ml of LB medium. (g / g: tryptone 10, yeast extract 5, NaCl 5; pH 7.2-7.5) at 37 ° C. on a rotating shaker (200 rpm) for 12-16 hours. Biomass from 2 ml of culture was separated from the media by centrifugation, washed with saline solution and stored at -20 ° C.

염색체 DNA를 상업적으로 유용한 컬럼 GENOMIC-TIP 100/G (Qiagen, 스위스) 및 적절한 완충액 키트 GENOMIC BUFFER SET (Qiagen)에 의해 해동된(de-frosted) 균체로부터 분리하였다.Chromosomal DNA was isolated from de-frosted cells by the commercially available column GENOMIC-TIP 100 / G (Qiagen, Switzerland) and the appropriate buffer kit GENOMIC BUFFER SET (Qiagen).

실시예 2Example 2

재조합 DNA 기술Recombinant DNA technology

제한 효소(Fermentas, 리투아니아)에 의한 DNA 절단, TBE 완충액 중에서 1.0% 아가로즈 겔(USB, 미국)에서 DNA 분자의 분석, T4 DNA 리가아제(Fermentas, 리투아니아)에 의한 접합(ligation)의 모든 방법을 표준 프로토콜(J. Sambrook, 1989)에 따라 수행하였다. PCR 반응 및 DNA 서열분석(DNA sequencing)을 위하여, MWG-Biotech AG 사 (독일) 및 Metabion 사 (독일)에 의해 프라이머(표 1)를 합성하였다. PCR 반응을 수행하기 위하여, Thermocycler PTC-200 (MJ-Research, Inc., 미국)를 사용하였으며, 모든 반응은 GC-RICH 용액(ROCHE, 스위스) 존재하에서 Pwo SuperYield DNA 폴리머라아제를 사용하여 수행하였다. PCR 기술의 산물의 크기는 TBE 완충액 중에서 1% 아가로즈 겔에서 결정하였으며, 여기서 제한 엔도뉴클레아제 PstI에 의해 절단된 파아지 λ(phage λ)의 DNA를 분자량 표준으로서 사용하였다. 추가적인 서브클로닝 또는 서열분석을 목적으로 한 PCR의 특정 산물은 QIAEX II Gel Extraction Kit (Qiagen, 독일)을 사용하여, 제조자 지침에 따라, 아가로즈 겔 로부터 분리하였다. 상기 독특한(unique) DNA 단편을 High Pure PCR Product Purification Kit (ROCHE, 스위스)로, 제조자 지침에 따라, 정제하였다. 컴피턴트(competent) 세포의 제조 및 숙주 균주의 형질전환은 J. Hanahan, MoI. Biol. 166: 557-580, 1983에 따라 수행하였으며, 여기서 원하는 PCR 단편을 갖는 플라스미드로 형질전환된 컴피턴트 세포를 16 시간 동안 37 ℃에서 항생제 카나마이신(Km, 50 μg/ml)으로 보충된 토양 배양 배지 Luria-Bertani (LB, g/1로: 트립톤 10, 효모 추출물 5, NaCl 5, 아가 15; pH 7.2-7.5) 상에서, 최종적으로 오비탈 교반기(orbital shaker) Gallenkamp (200 rpm) 상에서 Km으로 보충된 50 ml의 액체 LB 배지 중에서 배양하였다. 이어지는 분석을 위하여, 재조합 플라스미드를 Qiagen Plasmid Midi Kit (Qiagen, 독일) 및 High Pure Plasmid Isolation Kit (ROCHE, 스위스)를 사용하여, 제조자 지침에 따라, 분리하였다. 모든 NT DNA 서열의 결정은 3100 DNA Sequencer (Perkin-Elmer, 미국) 상에서 자동적으로, Institute of Microbiology AS CR에서 수행하였다. 얻어진 서열은 소프트웨어 Lasergene (DNASTAR Inc., 미국)로 분석하였다. NT 서열의 상동성은 소프트웨어 BLAST (National Center for Biotechnology Information, 미국; S. F. Altschul et al: Nucleic Acids Res. 25: 3389-3402, 1997)로 확인하였다.DNA cleavage by restriction enzymes (Fermentas, Lithuania), analysis of DNA molecules on 1.0% agarose gel (USB, USA) in TBE buffer, ligation by T4 DNA ligase (Fermentas, Lithuania) It was performed according to standard protocol (J. Sambrook, 1989). For PCR reaction and DNA sequencing, primers (Table 1) were synthesized by MWG-Biotech AG (Germany) and Metabion (Germany). To perform the PCR reaction, Thermocycler PTC-200 (MJ-Research, Inc., USA) was used and all reactions were performed using Pwo SuperYield DNA polymerase in the presence of GC-RICH solution (ROCHE, Switzerland). . The size of the product of the PCR technique was determined on a 1% agarose gel in TBE buffer, where DNA of phage λ digested by restriction endonuclease Pst I was used as molecular weight standard. Certain products of PCR for further subcloning or sequencing were isolated from agarose gels using the QIAEX II Gel Extraction Kit (Qiagen, Germany), according to the manufacturer's instructions. The unique DNA fragments were purified with High Pure PCR Product Purification Kit (ROCHE, Switzerland), according to manufacturer's instructions. Preparation of competent cells and transformation of host strains are described in J. Hanahan, MoI. Biol. 166: 557-580, 1983, wherein soil culture medium Luria supplemented with antibiotic kanamycin (Km, 50 μg / ml) at 37 ° C. for 16 hours transformed competent cells with plasmids with the desired PCR fragments. 50 on Bertani (LB, g / 1: tryptone 10, yeast extract 5, NaCl 5, agar 15; pH 7.2-7.5) and finally supplemented with Km on an orbital shaker Gallenkamp (200 rpm) Cultured in ml of liquid LB medium. For subsequent analysis, recombinant plasmids were isolated using Qiagen Plasmid Midi Kit (Qiagen, Germany) and High Pure Plasmid Isolation Kit (ROCHE, Switzerland), according to the manufacturer's instructions. Determination of all NT DNA sequences was performed automatically at the Institute of Microbiology AS CR on a 3100 DNA Sequencer (Perkin-Elmer, USA). The obtained sequence was analyzed by software Lasergene (DNASTAR Inc., USA). Homology of NT sequences was confirmed by software BLAST (National Center for Biotechnology Information, USA; SF Altschul et al: Nucleic Acids Res. 25: 3389-3402, 1997).

Figure 112009047105538-PCT00001
Figure 112009047105538-PCT00001

실시예 3Example 3

pga 유전자의 뉴클레오티드 서열 결정 및 발현 시스템의 제조Nucleotide Sequencing and Expression of pga Gene

균주 아크로모박터(Achromobacter) sp. CCM 4824의 염색체 DNA를 효소 Sau3AI로 부분적으로 절단하였다. 상기 DNA-단편들을 벡터 pK19 (RD. Pridmore: Gene 56, 309-312, 1987)의 BamHI-선형 플라스미드 DNA(BamHI-inearized plasmid DNA)와 접합(ligation)시켰다. 이어서, 얻어진 구조체를 숙주 균주 E. coli TOPlO의 형질전환에 사용하였다. 페니실린 아실라아제 표현형(PGA+)을 나타내는 재조합 균주 E. coli 로부터 분리된 플라스미드 pKAGSau401 (도 2)를 PstI에 의해 제한시켰다. 이어서, 가장 큰 PstI-단편(약 5.1 kb)을 PstI-선형 벡터 pK19에 서브클로닝하여, 반대로 배향된 PstI-삽입물을 갖는 2 종의 구조체, pKLP3 및 pKLP6 (도 2)를 형성시켰다. 재조합 균주 E. coli TOPlO(pKLP3) 및 E. coli TOP10(pKLP6)는 표현형 PGA+를 가졌다.Strain Achromobacter sp. Chromosome DNA of CCM 4824 was partially cut with the enzyme Sau3 AI. The DNA- fragments of vector pK19 (RD Pridmore:. Gene 56 , 309-312, 1987) in the Bam HI- linear plasmid DNA (Bam HI-inearized plasmid DNA ) and was bonded (ligation). The resulting construct was then used for transformation of host strain E. coli TOPlO. Plasmid pKAG Sau 401 (FIG. 2) isolated from recombinant strain E. coli showing a penicillin acylase phenotype (PGA + ) was limited by Pst I. Subsequently, the largest P st I-fragment (approximately 5.1 kb) was subcloned into the P st I-linear vector pK19, resulting in two constructs, pKLP3 and pKLP6 with oppositely oriented P st I-insertions (FIG. 2). Formed. Recombinant strains E. coli TOPlO (pKLP3) and E. coli TOP10 (pKLP6) had the phenotype PGA + .

분리된 플라스미드 pKLP3 및 pKLP6를, 범용(universal) M13/pUC 서열분석 프라이머 및 이어서 유래하는 pga-엄격히 특정한 프라이머(pga-strictly specific primers)를 사용하여, pga 유전자의 전체 뉴클레오티드 서열을 얻기 위한 주형으로서 사용하였다 (프라이머 목록 - 표 1 참조). 2592 뉴클레오티드를 갖는 구조 유전자 pga의 뉴클레오티드 서열(정지 트리플릿(termination triplet) TAA를 포함)은, 뉴클레오티드 63 내지 2592에 의해 정의된 부위에서, 관련 미생물 아크로모박터 크실로속시단스(Achromobacter xylosoxidans) ssp. 크실로속시단스(xylosoxidans) (GenBank AF490005)의 pga 유전자와 92% 동일성을 나타낸다.A separate plasmid and pKLP3 pKLP6, general-purpose (universal) M13 / pUC sequencing primers and subsequently derived from the pga] Using strictly specific primers (pga -strictly specific primers), used as the template for obtaining the complete nucleotide sequence of the pga gene (Primer list-see Table 1). The nucleotide sequence of the structural gene pga having 2592 nucleotides (including the stop triplet TAA) is, at the site defined by nucleotides 63 to 2592, the relevant microorganism Achromobacter xylosoxidans ssp. 92% identity to the pga gene of xylosoxidans (GenBank AF490005).

상기에서 얻어진 인접 부위를 포함한 상기 pga 유전자의 뉴클레오티드 서열에 기초하여, 균주 아크로모박터(Achromobacter) sp. CCM 4824의 염색체 DNA를 주형으로 하여, 구조 유전자 pga 의 PCR 증폭을 가능하게 하는 프라이머를 고안하였다. 삽입된 제한 부위 XbaI, resp. PstI을 갖는 구조 유전자 pga 에 인접한 부위로부터, 고안된 2개의 프라이머 UPACYLXba1 및 REVACYLPst1을 다음 단계를 포함하는 PCR 반응에서 사용하였다: 1) 94 ℃에서 5 분; 2) 94 ℃에서 45 초 동안 변성, 60 ℃에서 45 초 동안 프라이머들의 결합, 및 72 ℃에서 3 분 동안 중합의 30 사이클; 3) 72 ℃ 에서 10 분 동안 중합 종료. 상기 조건하에서, 샤인-달가로(Shine-Dalgarno) 서열을 갖는 조절 부위의 선행 부위를 포함하는 전체 구조 유전자 pga 를 지니고 있는, 2663 bp 크기의 특정 PCR 산물이 제조되었다. 상기 pga-특정한 PCR 산물을 제한 엔도뉴클레아제 XbaI로 절단하였으며 (UPACYLXbal 프라이머 중의 표적 서열), 이어서 벡터 pK19에 접합시키고, 2개의 폴리링커(polylinker) 효소 XbaI and SmaI 로 절단하였다. 얻어진 재조합 구조체를 pKX1P1 플라스미드로 지칭하였다 (도 1). 상기 플라스미드의 DNA 서열 분석은 PCR-산물의 삽입 과정에서 어떠한 삽입-결실 돌연변이도 발생하지 않은 것으로 나타났으나, 원래 가정한 뉴클레오티드 서열에 비하여 구조 유전자 pga 의 99번째 뉴클레오티드에서 부위 돌연변이 C → T가 발견되었다. 그러나, 상기 트리플렛(triplet)이 코딩하는 아미노산 형태를 변화시키기 않기 때문에, 상기 돌연변이는 침묵적(silent)이다. 영양(prototrophic) 숙주 균주 E. coli BL21 (Invitrogen, 미국)을 상기 분리된 재조합 플라스미드 pKLP6 및 pKX1P1로 형질전환시키고, PGA에 대한 원핵(prokaryotic) 발현 시스템 BL21(pKXlPl)을 제조하였다.Based on the nucleotide sequence of the pga gene including the adjacent site obtained above, strain Achromobacter sp. Using the chromosomal DNA of CCM 4824 as a template, a primer was designed to enable PCR amplification of the structural gene pga . Inserted restriction sites Xba I, resp. From the site adjacent to the structural gene pga with Pst I, two designed primers UPACYL Xba 1 and REVACYL Pst 1 were used in a PCR reaction comprising the following steps: 1) 5 minutes at 94 ° C .; 2) 30 cycles of denaturation at 94 ° C. for 45 seconds, binding of primers at 60 ° C. for 45 seconds, and polymerization at 72 ° C. for 3 minutes; 3) Termination of polymerization at 72 ° C. for 10 minutes. Under these conditions, a specific PCR product of 2663 bp size was prepared having the entire structural gene pga comprising the preceding site of the regulatory site with the Shine-Dalgarno sequence. The pga -specific PCR product was cleaved with restriction endonuclease Xba I (target sequence in UPACYL Xba l primer), then conjugated to vector pK19 and cleaved with two polylinker enzymes Xba I and Sma I. . The resulting recombinant construct was referred to as the pKX1P1 plasmid (FIG. 1). DNA sequencing of the plasmid revealed that no insertion-deletion mutations occurred during the PCR-product insertion, but site mutation C → T was found at the 99th nucleotide of the structural gene pga compared to the originally assumed nucleotide sequence. It became. However, because the triplet does not change the amino acid form that it encodes, the mutation is silent. The prototrophic host strain E. coli BL21 (Invitrogen, USA) was transformed with the isolated recombinant plasmids pKLP6 and pKX1P1, to produce a prokaryotic expression system BL21 (pKXlPl) for PGA.

실시예 4Example 4

에스케리치아 콜라이(Escherichia coli)에서의 상기 pga의 발현Expression of pga in Escherichia coli

에스케리치아 콜라이(Escherichia coli) BL21 (pKX1P1) 균주의 배양을 위한 접종물(inoculum)의 준비Preparation of Inoculum for Cultivation of Escherichia coli BL21 (pKX1P1) Strains

-70 ℃에서 보관된 글리세롤 보존물(J. Sambrook,1989에 따라 글리세롤과 혼합하여 키운 배지)로부터, 카나마이신(Km, 50 μg/ml)으로 보충된 50 ml의 LB 배지를 접종하였다. 상기 접종물을 16 시간 동안 28 ℃에서 오비탈 인큐베이터 교반기(orbital incubator shaker) Gallenkamp (200 rpm) 중에서 배양하였다. 50 ml of LB medium supplemented with kanamycin (Km, 50 μg / ml) was inoculated from glycerol reserves stored at −70 ° C. (medium grown with glycerol according to J. Sambrook, 1989). The inoculum was incubated in an orbital incubator shaker Gallenkamp (200 rpm) at 28 ° C. for 16 hours.

바이오반응기 중에서의 배양Culture in Bioreactor

균주 BL21 (pKX1P1)을, 엄격히 제한된 조건하에서, 탄소원 및 에너지원으로서 글리세롤(5-25 g/1) 및 카제인 가수분해물(5-25 g/1)로 보충된 M9 배지(표 2)에서, 교반되는 바이오반응기 Biostat MD (B. Braun Biotech Intl., Melsungen, 독일) 중에서 배양하였다: 조작 용적(working volume) 8.2 l, 공기 흐름 속도 8 - 9 l air/min, 초기 교반 횟수 200 내지 300 rpm, 20 내지 28 ℃ 범위의 온도에서. 배지의 pH는 7.5 내지 5.5의 범위로 유지시켰으며, 교반 횟수를 200 내지 840 rpm 범위로 조절함으로써 용존 산소의 농도(pO2)를 배지의 최대 산소 포화의 5 내지 30 % 범위로 자동적으로 유지시켰다. 상기 배양은 20 내지 25 시간 동안 유가 뱃치 배양으로 수행하였다 (도 3 및 4). 배양 종료시, 하기 파라미터를 측정하였다: 균체 농도 (세포 건조 중량, cdw), 총 활성(TA) 및 페니실린 아실라아제의 특이적 활성(SA).Strain BL21 (pKX1P1) was stirred in M9 medium (Table 2) supplemented with glycerol (5-25 g / 1) and casein hydrolyzate (5-25 g / 1) as carbon and energy sources under strictly limited conditions. Incubated in a bioreactor Biostat MD (B. Braun Biotech Intl., Melsungen, Germany): working volume 8.2 l, air flow rate 8-9 l air / min, initial agitation number 200-300 rpm, 20 At a temperature in the range from 28 [deg.] C. The pH of the medium was maintained in the range of 7.5 to 5.5, and the dissolved oxygen concentration (pO 2 ) was automatically maintained in the range of 5 to 30% of the maximum oxygen saturation of the medium by adjusting the number of stirrings in the range of 200 to 840 rpm. . The incubation was carried out in fed batch culture for 20-25 hours (FIGS. 3 and 4). At the end of the culture, the following parameters were measured: cell concentration (cell dry weight, cdw), total activity (TA) and specific activity of penicillin acylase (SA).

상기 파라미터는 다음과 같이 측정되었다: The parameter was measured as follows:

균체 농도: 배양 배지중 28 g cdw/lCell concentration: 28 g cdw / l in culture medium

총 활성: 배양 배지중 18 000 U/lTotal activity: 18 000 U / l in culture medium

특이적 활성: 670 U/g cdwSpecific activity: 670 U / g cdw

효소 활성 측정Enzyme Activity Measurement

PGA 효소 활성 측정을 위하여, 1 내지 2 ml 용적의 배양 샘플을 생산 배양물로부터 취하였다. 상기 균체를 원심분리로 분리하고, 1 내지 2 ml의 증류수로 세척한 후, 추가로 원심분리하여 -20 ℃에서 보관하였다. 해동된(de-frosted) 균체를 0.005 M 인산 완충액(pH 8.0) 중에 재현탁시켰다. PGA의 활성을 37 ℃에서 기질로서 페니실린 G를 사용하여 적정함으로써 측정하였다.For PGA enzyme activity determination, culture samples in volumes of 1-2 ml were taken from the production culture. The cells were separated by centrifugation, washed with 1-2 ml of distilled water, and further centrifuged and stored at -20 ° C. De-frosted cells were resuspended in 0.005 M phosphate buffer (pH 8.0). The activity of PGA was measured by titration using penicillin G as substrate at 37 ° C.

배양 배지 M9 중의 성분Components in Culture Medium M9 물질matter 화학식Chemical formula 농도(g/L)Concentration (g / L) 황산암모늄(ammonium sulphate)Ammonium sulphate (NH4)2SO4 (NH 4 ) 2 SO 4 4.04.0 인산이수소칼륨(potassium dihydrogen phosphate)Potassium dihydrogen phosphate KH2PO4 KH 2 PO 4 13.613.6 염화나트륨Sodium chloride NaClNaCl 10.010.0 수산화나트름Hydroxide hydroxide NaOHNaOH 3.03.0 황산마그네슘Magnesium sulfate MgSO4·7H2OMgSO 4 7 H 2 O 2.02.0 염화칼슘Calcium chloride CaCl2·6H2OCaCl 2 · 6H 2 O 0.050.05 황산 제1철(ferrous sulphate)Ferrous sulphate FeSO4·7H2OFeSO 4 7H 2 O 0.010.01

본 발명의 뉴클레오티드 서열을 포함하는 미생물의 재조합 균주는 화학 및 제약 산업에서 다양한 응용을 위한 페니실린 아실라아제의 생산에 사용될 수 있다.Recombinant strains of microorganisms comprising the nucleotide sequences of the present invention can be used in the production of penicillin acylase for various applications in the chemical and pharmaceutical industries.

<110> FERMENTA BIOTECH LIMITED MIKROBIOLOGICKY USTAC AVCR v.v.i. <120> DNA SEQUENCE ENCODING PENICILLIN ACYLASE NOVEL RECOMBINANT DNA CONSTRUCTS AND RECOMBINANT MICROORGANISMS CARRYING THIS SEQUENCE <130> PN0286 <150> PV 2007-82 <151> 2007-01-31 <160> 1 <170> KopatentIn 1.71 <210> 1 <211> 2646 <212> DNA <213> Artificial sequence <220> <221> misc_feature <222> (1)..(2646) <223> Achromobacter Species CCM 4824; Recombinant DNA <400> 1 cggagacaga ttcaatgaag cagcaatggt tgtcggccgc cctgttggcg gccagttcgt 60 gcctgcccgc gatggcggcg cagccggtgg cgccagccgc cggccagacg tccgaggcgg 120 ttgcggcacg gccccaaacc gccgatggca aggtcacgat ccggcgcgat gcctacggca 180 tgccgcatgt ctatgccgac acggtgtacg gcatcttcta cggctacggc tacgcggtgg 240 cgcaggaccg gctgttccag atggagatgg cgcggcgcag cacccagggc cgggtggccg 300 aggtgctggg cgcctcgatg gtgggcttcg acaagtcgat ccgcgccaat ttctcgcccg 360 agcgcatcca gcgccagttg gcggcgctgc cggccgccga ccgccaggtg ctggacggct 420 acgcggctgg catgaacgcc tggctggcgc gggtgcgggc ccagccgggc caactgatgc 480 ccaaggaatt caatgacctg ggtttcgcgc cggccgactg gaccgcctac gacgtggcga 540 tgatcttcgt cggcaccatg gccaaccgct tttcggacgc caacagcgag atcgacaacc 600 tggcgctgct gacggcgttg aaggaccggc atggcgccgc cgatgccatg cgcatcttca 660 accagttgcg ctggctgacc gacagccgcg cgccgaccac ggtgccggcc gaagcgggca 720 gctaccagcc gccggtgttc cagccggacg gcgcggaccc gctggcctac gcgctgccgc 780 gctacgacgg cacgccgccg atgctcgagc gggtggtgcg cgacccggcc acgcggggcg 840 tggtcgacgg cgcgccggcg acgctgcggg cgcaactggc cgcccaatac gcgcaatcgg 900 gccagcccgg catcgccggc tttccgacca ccagcaatat gtggatcgtg ggccgcgacc 960 acgccaagga cgcgcgctcg atcctgctga acggcccgca gttcggctgg tggaatccgg 1020 cctataccta cggcatcggc ttgcacggcg ccggcttcga cgtggtcggc aacacgccgt 1080 tcgcctatcc cagcattctg ttcggccaca atgcacacgt gacgtggggt tcgaccgcgg 1140 gcttcggcga tgacgtcgac atctttgccg aaaagctcga tcccgccgac cgcacgcgct 1200 atttccacga cggccaatgg aagacgctgg aaaagcgcac cgacctgatc ctggtgaagg 1260 acgcggcgcc agtgacgctg gacgtgtacc gcagcgtgca tggcctgatc gtcaagttcg 1320 acgacgcgca gcacgtggcc tacgccaagg cgcgcgcctg ggaaggctat gaactgcaat 1380 cgctgatggc ctggacccgc aagacgcaat cggccaactg ggaacagtgg aaggcgcagg 1440 cggcgcgcca tgcgctgacc atcaactggt actacgccga cgaccgcggc aacattggct 1500 acgcgcacac gggcttctat cccaggcgcc gtccgggcca cgatccgcgc ctgccggtgc 1560 ccggcaccgg cgagatggac tggctgggcc tgctgccgtt ctctaccaat ccgcaggtct 1620 acaacccgcg ccagggcttc atcgccaact ggaacaacca gccgatgcgc ggctacccgt 1680 ccaccgacct gttcgccatc gtctggggcc aggccgaccg ctacgccgag atcgagacgc 1740 gcctgaaggc catgaccgcg aacggaggca aggtcagcgc gcagcagatg tgggacctga 1800 tccgcaccac cagctacgcc gacgtcaacc gccgtcattt cctgccgttc ctgcaacgcg 1860 cggtgcaagg gctgccggcg gatgatccgc gcgtgcgcct ggtggccggc ctggcggcct 1920 gggacggcat gatgaccagc gagcgccaac cgggttactt cgacaacgcc ggcccggcgg 1980 tcatggacgc gtggctgcgc gccatgctgc ggcgcacgct ggccgacgag atgccggccg 2040 acttcttcaa gtggtacagc gccaccggct acccgacacc gcaggcgccg gccaccggtt 2100 cgctcaacct gaccaccggc gtcaaggtgc tgttcaacgc cctggccggg cccgaggctg 2160 gcgtgccgca gcgctatgac ttcttcaacg gcgcgcgcgc cgacgacgtc atcctcgcgg 2220 cgctggacga tgcgctggcg gcgctgcgcc aggcctatgg ccaggatccg gcggcatgga 2280 agatcccggc gccgccgatg gtgttcgcgc ccaagaactt cctgggcgtg ccgcaggccg 2340 acgccaaggc ggtgctgtgc tatcgggcca cgcagaaccg cggcaccgag aacaacatga 2400 cggtgttcga cggtaaatcg gtgcgcgcgg tggatgtggt ggcgccgggg cagagcggct 2460 tcgtcgcccc ggacggcacg ccgtcgccgc acacccgcga ccagttcgac ctgtacaaca 2520 ccttcggcag caaacgggtg tggttcacgg ccgatgaggt gcggcgcaac gctacgtcgg 2580 aagagacgtt gcgctacccg cggtaaggtc gcgcgcgccc tggtggctgg caagcctgca 2640 gtacac 2646 <110> FERMENTA BIOTECH LIMITED          MIKROBIOLOGICKY USTAC AVCR v.v.i. <120> DNA SEQUENCE ENCODING PENICILLIN ACYLASE NOVEL RECOMBINANT DNA          CONSTRUCTS AND RECOMBINANT MICROORGANISMS CARRYING THIS SEQUENCE <130> PN0286 <150> PV 2007-82 <151> 2007-01-31 <160> 1 <170> KopatentIn 1.71 <210> 1 <211> 2646 <212> DNA <213> Artificial sequence <220> <221> misc_feature (222) (1) .. (2646) Achromobacter Species CCM 4824; Recombinant DNA <400> 1 cggagacaga ttcaatgaag cagcaatggt tgtcggccgc cctgttggcg gccagttcgt 60 gcctgcccgc gatggcggcg cagccggtgg cgccagccgc cggccagacg tccgaggcgg 120 ttgcggcacg gccccaaacc gccgatggca aggtcacgat ccggcgcgat gcctacggca 180 tgccgcatgt ctatgccgac acggtgtacg gcatcttcta cggctacggc tacgcggtgg 240 cgcaggaccg gctgttccag atggagatgg cgcggcgcag cacccagggc cgggtggccg 300 aggtgctggg cgcctcgatg gtgggcttcg acaagtcgat ccgcgccaat ttctcgcccg 360 agcgcatcca gcgccagttg gcggcgctgc cggccgccga ccgccaggtg ctggacggct 420 acgcggctgg catgaacgcc tggctggcgc gggtgcgggc ccagccgggc caactgatgc 480 ccaaggaatt caatgacctg ggtttcgcgc cggccgactg gaccgcctac gacgtggcga 540 tgatcttcgt cggcaccatg gccaaccgct tttcggacgc caacagcgag atcgacaacc 600 tggcgctgct gacggcgttg aaggaccggc atggcgccgc cgatgccatg cgcatcttca 660 accagttgcg ctggctgacc gacagccgcg cgccgaccac ggtgccggcc gaagcgggca 720 gctaccagcc gccggtgttc cagccggacg gcgcggaccc gctggcctac gcgctgccgc 780 gctacgacgg cacgccgccg atgctcgagc gggtggtgcg cgacccggcc acgcggggcg 840 tggtcgacgg cgcgccggcg acgctgcggg cgcaactggc cgcccaatac gcgcaatcgg 900 gccagcccgg catcgccggc tttccgacca ccagcaatat gtggatcgtg ggccgcgacc 960 acgccaagga cgcgcgctcg atcctgctga acggcccgca gttcggctgg tggaatccgg 1020 cctataccta cggcatcggc ttgcacggcg ccggcttcga cgtggtcggc aacacgccgt 1080 tcgcctatcc cagcattctg ttcggccaca atgcacacgt gacgtggggt tcgaccgcgg 1140 gcttcggcga tgacgtcgac atctttgccg aaaagctcga tcccgccgac cgcacgcgct 1200 atttccacga cggccaatgg aagacgctgg aaaagcgcac cgacctgatc ctggtgaagg 1260 acgcggcgcc agtgacgctg gacgtgtacc gcagcgtgca tggcctgatc gtcaagttcg 1320 acgacgcgca gcacgtggcc tacgccaagg cgcgcgcctg ggaaggctat gaactgcaat 1380 cgctgatggc ctggacccgc aagacgcaat cggccaactg ggaacagtgg aaggcgcagg 1440 cggcgcgcca tgcgctgacc atcaactggt actacgccga cgaccgcggc aacattggct 1500 acgcgcacac gggcttctat cccaggcgcc gtccgggcca cgatccgcgc ctgccggtgc 1560 ccggcaccgg cgagatggac tggctgggcc tgctgccgtt ctctaccaat ccgcaggtct 1620 acaacccgcg ccagggcttc atcgccaact ggaacaacca gccgatgcgc ggctacccgt 1680 ccaccgacct gttcgccatc gtctggggcc aggccgaccg ctacgccgag atcgagacgc 1740 gcctgaaggc catgaccgcg aacggaggca aggtcagcgc gcagcagatg tgggacctga 1800 tccgcaccac cagctacgcc gacgtcaacc gccgtcattt cctgccgttc ctgcaacgcg 1860 cggtgcaagg gctgccggcg gatgatccgc gcgtgcgcct ggtggccggc ctggcggcct 1920 gggacggcat gatgaccagc gagcgccaac cgggttactt cgacaacgcc ggcccggcgg 1980 tcatggacgc gtggctgcgc gccatgctgc ggcgcacgct ggccgacgag atgccggccg 2040 acttcttcaa gtggtacagc gccaccggct acccgacacc gcaggcgccg gccaccggtt 2100 cgctcaacct gaccaccggc gtcaaggtgc tgttcaacgc cctggccggg cccgaggctg 2160 gcgtgccgca gcgctatgac ttcttcaacg gcgcgcgcgc cgacgacgtc atcctcgcgg 2220 cgctggacga tgcgctggcg gcgctgcgcc aggcctatgg ccaggatccg gcggcatgga 2280 agatcccggc gccgccgatg gtgttcgcgc ccaagaactt cctgggcgtg ccgcaggccg 2340 acgccaaggc ggtgctgtgc tatcgggcca cgcagaaccg cggcaccgag aacaacatga 2400 cggtgttcga cggtaaatcg gtgcgcgcgg tggatgtggt ggcgccgggg cagagcggct 2460 tcgtcgcccc ggacggcacg ccgtcgccgc acacccgcga ccagttcgac ctgtacaaca 2520 ccttcggcag caaacgggtg tggttcacgg ccgatgaggt gcggcgcaac gctacgtcgg 2580 aagagacgtt gcgctacccg cggtaaggtc gcgcgcgccc tggtggctgg caagcctgca 2640 gtacac 2646  

Claims (10)

2646 bp 크기의 뉴클레오티드 서열로서, 상기 뉴클레오티드 서열이 도 5에 나타낸 뉴클레오티드 서열과 적어도 95%의 동일성을 갖는 뉴클레오티드 서열.Nucleotide sequence of size 2646 bp, wherein the nucleotide sequence has at least 95% identity with the nucleotide sequence shown in FIG. 페니실린 아실라아제를 코딩하는, 적어도 150 뉴클레오티드의 길이를 갖는, 제1항에 따른 뉴클레오티드 서열의 단편.A fragment of the nucleotide sequence of claim 1, having a length of at least 150 nucleotides, encoding penicillin acylase. 제1항에 따른 뉴클레오티드 서열 또는 제2항에 따른 뉴클레오티드 서열의 단편을 포함하는 핵산 구조체로서, 상기 유전자의 발현 및 페니실린 아실라아제 활성을 갖는 폴리펩타이드의 생산을 조절하는 적어도 하나의 조절 서열을 갖는 핵산 구조체.A nucleic acid construct comprising a nucleotide sequence according to claim 1 or a fragment of a nucleotide sequence according to claim 2, wherein said nucleic acid construct has at least one regulatory sequence that regulates the expression of said gene and the production of a polypeptide having penicillin acylase activity. Nucleic Acid Constructs. 제1항에 따른 뉴클레오티드 서열 또는 제2항에 따른 뉴클레오티드 서열의 단편을 포함하는 재조합 플라스미드.A recombinant plasmid comprising a nucleotide sequence according to claim 1 or a fragment of a nucleotide sequence according to claim 2. 제3항에 따른 핵산 구조체, 프로모터, 번역 개시 신호, 및 번역과 전사 정지 신호로 구성된 재조합 발현 벡터.A recombinant expression vector consisting of a nucleic acid construct according to claim 3, a promoter, a translation initiation signal, and a translational and transcriptional stop signal. 제3항에 따른 핵산 구조체를 포함하는 숙주 세포.A host cell comprising the nucleic acid construct of claim 3. 제6항에 있어서, 상기 핵산 구조체가 제5항에 따른 재조합 발현 벡터 중에 유지되는 것을 특징으로 하는 숙주 세포.7. The host cell of claim 6, wherein said nucleic acid construct is maintained in a recombinant expression vector according to claim 5. 제6항에 있어서, 상기 핵산 구조체가 상기 세포 게놈으로 통합(integration)되는 것을 특징으로 하는 숙주 세포.7. The host cell of claim 6, wherein said nucleic acid construct is integrated into said cell genome. 제1항에 따른 뉴클레오티드 서열이 삽입되고, 균주 아크로모박터(Achromobacter) sp.로부터 분리되고, 또한 도 1 및 2에 따른 제한 지도를 특징으로 하는, 재조합 플라스미드 pKX1P1, pKLP3 및 pKLP6.Recombinant plasmids pKX1P1, pKLP3 and pKLP6, wherein the nucleotide sequences according to claim 1 are inserted, isolated from strain Achromobacter sp., And also characterized by restriction maps according to FIGS. 1 and 2. 제9항에 따른 플라스미드 pKX1P1, pKLP3 및 pKLP6에 의해 전달되는 제1항에 따른 서열을 포함하는 균주 에스케리치아 콜라이 (Escherichia coli) BL21.Strain Escherichia coli BL21 comprising the sequence according to claim 1 carried by the plasmids pKX1P1, pKLP3 and pKLP6 according to claim 9.
KR1020097016144A 2007-01-31 2007-05-15 Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence KR20090114380A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20070082A CZ300467B6 (en) 2007-01-31 2007-01-31 Penicillin acylase encoding nucleotide sequence having the size of (2646) bp, new recombinant nucleic acid constructs and recombinant microorganisms carrying this sequence
CZPV2007-82 2007-01-31

Publications (1)

Publication Number Publication Date
KR20090114380A true KR20090114380A (en) 2009-11-03

Family

ID=39171372

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097016144A KR20090114380A (en) 2007-01-31 2007-05-15 Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence

Country Status (6)

Country Link
US (1) US8039604B2 (en)
EP (1) EP2109672A1 (en)
KR (1) KR20090114380A (en)
CN (1) CN101563459A (en)
CZ (1) CZ300467B6 (en)
WO (1) WO2008093351A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101802212B (en) 2007-07-27 2013-08-28 酵素生物技术有限公司 Process for the preparation of immobilized recombinant penicillin acylase catalyst from Achromobacter sp. CCM 4824 expressed in E. coli BL 21 CCM 7394 and its use for the synthesis of beta-lactam antibiotics
CN103184182B (en) * 2013-04-11 2015-02-11 南京工业大学 Penicillin acylase, as well as high-yield strain and application thereof
CN103805671B (en) * 2013-11-11 2015-08-26 华北制药河北华民药业有限责任公司 A kind of method preparing Cephalexin Monohydrate Micro/Compacted
CN104789510A (en) * 2015-05-06 2015-07-22 南京工业大学 Penicillin acylase as well as encoding gene, producing strain and application thereof
CN110106161B (en) * 2019-05-09 2022-03-22 福建医科大学附属口腔医院 Penicillin acylase gene and protein coded by same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790075A (en) * 1971-10-14 1973-04-13 Bayer Ag PROCESS FOR PREPARING PURE CRYSTALLINE PENICILLINACYLASE AND OBTAINED PRODUCT
US5168048A (en) * 1990-04-18 1992-12-01 Gist-Brocades Nv Penicillin G acylase, a gene encoding the same and a method for the production of this enzyme
NZ247464A (en) 1992-04-24 1994-12-22 Lilly Co Eli Preparation of 2-amino-acetamidocephalosporin derivatives, the 2-acetamido group substituted in the 2-position by a c5-6 cyclic hydrocarbon or a c5-heterocycle
PT638649E (en) 1993-08-05 2000-04-28 Dsm Nv NEW USE OF PENICILLIN G ACILLASE OF FALCALISAL ALKALIGINS
AU2881595A (en) 1994-06-10 1996-01-05 Gist-Brocades B.V. Improved acylation method for penicillins and cephalosporins
CN1159444C (en) * 1994-08-12 2004-07-28 Dsm公司 Mutated penicilling acylase genes
EP0839192B1 (en) 1995-07-18 2008-12-10 DSM IP Assets B.V. An improved immobilized penicillin g acylase
TW555855B (en) 1996-07-26 2003-10-01 Bristol Myers Squibb Co Synthesis of beta-lactam antibacterials using soluble side chain esters and enzyme acylase
US5850019A (en) 1996-08-06 1998-12-15 University Of Kentucky Research Foundation Promoter (FLt) for the full-length transcript of peanut chlorotic streak caulimovirus (PCLSV) and expression of chimeric genes in plants
CZ291154B6 (en) * 2001-08-03 2002-12-11 Mikrobiologický Ústav Av Čr Strain of Comamonas testosteroni CCM 4824 microorganism

Also Published As

Publication number Publication date
US8039604B2 (en) 2011-10-18
US20100112673A1 (en) 2010-05-06
WO2008093351A1 (en) 2008-08-07
CZ200782A3 (en) 2009-05-27
CZ300467B6 (en) 2009-05-27
CN101563459A (en) 2009-10-21
EP2109672A1 (en) 2009-10-21

Similar Documents

Publication Publication Date Title
Wilms et al. High‐cell‐density fermentation for production of L‐N‐carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter
US5635391A (en) Isolated DNA encoding a nitrilase polypeptide, hosts containing, and expression thereof optionally assisted by a E. coli GroE chaperone polypeptide
Wilms et al. Development of an Escherichia coli whole cell biocatalyst for the production of L-amino acids
JP3016449B2 (en) Cephalosporin C acylase
EP0453048A1 (en) Mutated beta-lactam acylase genes
KR0152667B1 (en) Penicillin g acylase and encoding gene
WO2003055998A2 (en) Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase
KR20090114380A (en) Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence
EP1051501A1 (en) Nucleic acid molecule encoding a cephalosporin acetylesterase
AU5248698A (en) Mutant penicillin g acylases
JP3408737B2 (en) Protein involved in nitrile hydratase activation and gene encoding the same
Mitsushima et al. Gene cloning, nucleotide sequence, and expression of a cephalosporin-C deacetylase from Bacillus subtilis
AU4046699A (en) Industrial method for producing heterologous proteins in E.coli and strains useful for said method
Kim et al. Cloning and high expression of glutaryl 7-aminocephalosporanic acid acylase gene from Pseudomonas diminuta
WO1996002636A1 (en) Genes encoding and method of expressing a novel enzyme: phthalyl amidase
KR100211002B1 (en) Process for the preparation of glutarylacylase in large quantities
Lee et al. Mass production of thermostable D‐hydantoinase by batch culture of recombinant Escherichia coli with a constitutive expression system
Velasco et al. Cloning and characterization of the gene cah B encoding a cephalosporin C acetylhydrolase from Acremonium chrysogenum
Hardianto et al. Cephalosporin C acylase from microbes for one-step enzymatic transformation of cephalosporin C to 7-aminocephalosporanic acid
EP1974029A2 (en) Mutant acylases
JP6156442B2 (en) Microorganisms that have replaced the nitrile hydratase gene
EP1902140A2 (en) Mutant expandases and their use in the production of beta-lactam compounds
RU2502797C1 (en) STRAIN Escherichia coli - PRODUCER OF HYDROLASE OF ALPHA-AMINO ACIDS FROM Xanthomonas rubrilineans, AND METHOD FOR MICROBIOLOGICAL SYNTHESIS OF HYDROLASE OF ALPHA-AMINO ACIDS ESTERS BASED ON ABOVE SAID STRAIN
RU2499830C1 (en) RECOMBINANT STRAIN Escherichia coli-PRODUCER OF HYDROLASE OF ALPHA-AMINO ACIDS ESTERS FROM Xanthomonas rubrilineans, METHOD FOR MICROBIOLOGICAL SYNTHESIS OF HYDROLASE OF ALPHA-AMINO ACIDS ESTERS BASED ON ABOVE SAID STRAIN
AU2021442655A1 (en) Corynebacterium glutamicum variant having improved l-lysine production ability, and method for producing l-lysine by using same

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application